Back

Explore every episode of the podcast JAMA Medical News

Dive into the complete episode list for JAMA Medical News. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

Rows per page:

1–50 of 313

TitlePub. DateDuration
Highlights From Kidney Week 202606 Nov 202600:15:41

Hear the latest on SGLT2 inhibitors, potassium binders, pregnancy after kidney donation, and more from Kidney Week 2026 with Keisha Gibson, MD, MPH, cochair of the Kidney Week education committee.

Related Content:

The Push for Waist Circumference Measurement06 Nov 202600:05:57

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Waist Circumference Adds to BMI, but Will Clinicians Adopt It?"

Related Content:

What Pennsylvania's Measles Outbreak Signals to the Nation30 Oct 202600:04:45

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is the Pennsylvania Measles Outbreak the New Normal?"

Related Content:

More Women Than Ever Are Using Testosterone23 Oct 202600:05:45

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Use Rises Among Women, but Does the Evidence Support It?"

Related Content:

What's Next for Lp(a)?16 Oct 202600:06:02

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?"

Related Content:

The Black Market for Investigational GLP-1 Drugs09 Oct 202600:05:59

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain."

Related Content:

What Happens When Children Use AI for Support?02 Oct 202600:05:14

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss 1 in 5 Children Report Using AI for Emotional Support--Is It Good News or Bad?

Related Content:

Ovarian Cancer Is a Misnomer25 Sep 202600:05:43

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance."

Related Content:

The Challenge of Diagnosing Adult ADHD18 Sep 202600:05:32

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right."

Related Content:

Researchers Turn to Viruses to Treat UTIs11 Sep 202600:05:38

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is Phage Therapy the Next Big Hope for Urinary Tract Infections?"

Related Content:

A New Definition of MI and Other Heart Health Highlights From ESC Congress 202611 Sep 202600:25:05

Hear about a new universal definition of myocardial infarction, updated heart failure guidelines, and other clinical highlights in this interview with Tomasz Guzik, MD, PhD, chair of this year's European Society of Cardiology Congress.

Related Content:

The Fascinating Road to a New Narcolepsy Treatment09 Sep 202600:38:39

The winners of the 2026 Albert Lasker Basic Medical Research Award, Emmanuel Mignot, MD, PhD, and Masashi Yanagisawa, MD, PhD, discuss how they identified the neuropeptide orexin and deduced its role in narcolepsy.

Related Content:

What the Latest Research Says About Preventing Dementia04 Sep 202600:05:38

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far."

Related Content:

Considering Cognition and Frailty in Cardiovascular Care—Too Big an Ask?28 Aug 202600:05:06

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement."

Related Content:

The Tip of the Iceberg Lettuce21 Aug 202600:05:29

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance."

Related Content:

FDA Approves the First mRNA Flu Vaccine for the US14 Aug 202600:05:43

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA."

Related Content:

The Slow Evolution of Lyme Disease Care07 Aug 202600:05:25

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Will New Lyme Disease Approaches Change Patient Care?"

Related Content:

Highlights From the 2026 Alzheimer's Association International Conference31 Jul 202600:30:59

Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD.

Related Content:

Striking the Balance for Prescribing Opioids31 Jul 202600:05:22

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?"

Related Content:

The Menopause Treatment Boom24 Jul 202600:05:26

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace."

Related Content:

The First CKM Syndrome Guidelines Are Here17 Jul 202600:05:10

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines."

Related Content:

The Testosterone Therapy Debate10 Jul 202600:05:32

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?"

Related Content:

Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected02 Jul 202600:05:32

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds."

Related Content:

PMOS is the New PCOS26 Jun 202600:05:35

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?"

Related Content:

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions18 Jun 202600:22:49

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more.

Related Content:

Why Exercise Still Matters in the GLP-1 Drug Era18 Jun 202600:04:57

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA."

Related Content:

The Search for a Fentanyl Vaccine12 Jun 202600:05:32

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine."

Related Content:

New Insights on HFpEF in Patients With Severe Obesity05 Jun 202600:04:48

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity."

Related Content:

Is There a Doctor on the Ship?29 May 202600:17:03

Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern.

Related Content:

Ebola Outbreak Update29 May 202600:06:20

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know."

Related Content:

Bangladesh's New Measles Crisis22 May 202600:04:51

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World."

Related Content:

New Obesity Definition Stirs Debate15 May 202600:06:06

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed."

Related Content:

Multi-Cancer Blood Tests Have Arrived08 May 202600:06:43

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?"

Related Content:

Why GLP-1 Drugs Affect Patients Differently01 May 202600:05:02

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics."

Related Content:

Treating Methamphetamine Use Disorder With an Antidepressant24 Apr 202600:03:36

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?"

Related Content:

Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory17 Apr 202600:05:44

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring."

Related Content:

Cancer-Treating Vaccines Are on the Horizon10 Apr 202600:06:51

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer."

Related Content:

Highlights From the American College of Cardiology's 2026 Scientific Sessions10 Apr 202600:20:30

Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting.

Related Content:

What Happens When Patients With Decompensated Cirrhosis Stop Drinking?03 Apr 202600:05:00

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking."

Related Content:

What's New in the Updated Lipid Guidelines?27 Mar 202600:05:23

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines."

Related Content:

The Health Costs of EPA's Heavy Metal Air Pollution Rollbacks20 Mar 202600:04:59

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern."

Related Content:

PrEP Prevents HIV—If Patients Can Get It13 Mar 202600:06:06

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era."

Related Content:

AI Tools for Patients Have Arrived06 Mar 202600:06:06

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?"

Related Content:

Why the Low Carb vs Low Fat Debate Misses the Point27 Feb 202600:04:28

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health."

Related Content:

What's New in the Dietary Guidelines for Americans?20 Feb 202600:05:24

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What Nutrition Experts Say About the New Dietary Guidelines for Americans."

Related Content:

ICE Raids Are Jeopardizing Health Care Access13 Feb 202600:06:03

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "US Patients Getting ICE-d-Out of Health Care."

Related Content:

Understanding COVID-19 Vaccine–Associated Myocarditis06 Feb 202600:05:19

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis."

Related Content:

What's Next in Weight-Loss Drugs?30 Jan 202600:06:20

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year."

Related Content:

How Stress May Connect Mental Health and Cardiovascular Disease23 Jan 202600:04:39

In this week's roundup, Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Stress May Link Depression and Anxiety to Cardiovascular Disease."

Related Content:

FDA Approves the First Oral GLP-1 Drug for Obesity16 Jan 202600:05:19

In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the Wegovy Pill for Obesity" and more.

Related Content:

© My Podcast Data · Independent project · Data from Apple & Spotify